Yuandong Yu

Shiyan, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

Sex-based heterogeneity in response to first-line immunotherapy plus chemotherapy in advanced esophageal squamous-cell carcinoma: a meta-analysis.

Sex-based heterogeneity in response to first-line immunotherapy plus chemotherapy in advanced esophageal squamous-cell carcinoma: a meta-analysis.

Journal: Frontiers in immunology
Published: January 10, 2026

Valid Analysis of Brain-Specific Progression-Free Survival.

Valid Analysis of Brain-Specific Progression-Free Survival.

Journal: JAMA oncology
Published: June 13, 2024

Depiction of neuroendocrine features associated with immunotherapy response using a novel one-class predictor in lung adenocarcinoma.

Depiction of neuroendocrine features associated with immunotherapy response using a novel one-class predictor in lung adenocarcinoma.

Journal: Discover oncology
Published: March 09, 2023

Heparanase is a prognostic biomarker independent of tumor purity and hypoxia based on bioinformatics and immunohistochemistry analysis of esophageal squamous cell carcinoma.

Heparanase is a prognostic biomarker independent of tumor purity and hypoxia based on bioinformatics and immunohistochemistry analysis of esophageal squamous cell carcinoma.

Journal: World journal of surgical oncology
Published: January 01, 2022

HNRNPL Is Identified and Validated as a Prognostic Biomarker Associated with Microsatellite Instability in Human Gastric Cancer.

HNRNPL Is Identified and Validated as a Prognostic Biomarker Associated with Microsatellite Instability in Human Gastric Cancer.

Journal: DNA and cell biology
Published: September 07, 2021

Efficacy and Safety of Berberine Alone for Several Metabolic Disorders: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.

Efficacy and Safety of Berberine Alone for Several Metabolic Disorders: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.

Journal: Frontiers in pharmacology
Published: January 15, 2021

Berberine ameliorates neuronal AD-like change via activating Pi3k/PGCε pathway.

Berberine ameliorates neuronal AD-like change via activating Pi3k/PGCε pathway.

Journal: BioFactors (Oxford, England)
Published: January 13, 2021

Downregulation of RIG-I mediated by ITGB3/c-SRC/STAT3 signaling confers resistance to interferon-α-induced apoptosis in tumor-repopulating cells of melanoma.

Downregulation of RIG-I mediated by ITGB3/c-SRC/STAT3 signaling confers resistance to interferon-α-induced apoptosis in tumor-repopulating cells of melanoma.

Journal: Journal for immunotherapy of cancer
Published: February 05, 2020

Macrophages reprogrammed by lung cancer microparticles promote tumor development via release of IL-1β.

Macrophages reprogrammed by lung cancer microparticles promote tumor development via release of IL-1β.

Journal: Cellular & molecular immunology
Published: May 28, 2019

Hypoxia-reprogrammed tricarboxylic acid cycle promotes the growth of human breast tumorigenic cells.

Hypoxia-reprogrammed tricarboxylic acid cycle promotes the growth of human breast tumorigenic cells.

Journal: Oncogene
Published: March 31, 2019

Enhanced mitochondrial pyruvate transport elicits a robust ROS production to sensitize the antitumor efficacy of interferon-γ in colon cancer.

Enhanced mitochondrial pyruvate transport elicits a robust ROS production to sensitize the antitumor efficacy of interferon-γ in colon cancer.

Journal: Redox biology
Published: August 15, 2018

Hydroxychloroquine induced lung cancer suppression by enhancing chemo-sensitization and promoting the transition of M2-TAMs to M1-like macrophages.

Hydroxychloroquine induced lung cancer suppression by enhancing chemo-sensitization and promoting the transition of M2-TAMs to M1-like macrophages.

Journal: Journal of experimental & clinical cancer research : CR
Published: May 02, 2018
Showing 1-12 of 17

Last Updated: 09/26/2026